Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-14

Clinical Trial Update: Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the safety and efficacy of a dextromethorphan/quinidine combination for the pain of diabetic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan/quinidine (dextromethorphan/quinidine)
  • NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

Sponsor: Avanir Pharmaceuticals | Conditions: Pain, Diabetic Neuropathy | Phase 3 | Status: COMPLETED